Our goal is to bring multiple therapeutics to the clinic for rare AND Neglected diseases


Collaborations Pharmaceuticals, Inc. performs research and development on innovative therapeutics for multiple rare and infectious diseases. We partner with academics or companies to identify and translate early preclinical to clinical stage assets

We have several assets in our pipeline available for partnering - contact us for more details.

We have developed Assay Central as our machine learning platform to create and build our drug pipeline. This can also be applied to develop models for toxicology - Try it here.

If you are a CLN1 family and want to hear more about what we are doing please contact us.


Funded by:



Find out about our mission.

Learn More →